Hypofractionated proton beam therapy for centrally located lung cancer.
Naoki NakamuraKenji HottaSadamoto ZendaHiromi BabaSatoe KitoTsunemichi AkitaAtsushi MotegiHidehiro HojoMasaki NakamuraRaturi Vijay ParshuramMasayuki OkumuraTetsuo AkimotoPublished in: Journal of medical imaging and radiation oncology (2019)
Hypofractionated PBT may be a very safe and effective treatment option for centrally located early lung cancer.